Improvement of Care & Outcome
How do outcomes measures for T1DM vary from country to country? This study used HbA1c data from population and clinic-based registries to see what levels of glycaemic control are being achieved, stratified by age and sex.
Overall, the researchers obtained HbA1c data on 324,501 patients with T1DM, from the following countries: Australia, Austria, Denmark, England, France, Germany, Greece, Italy, Latvia, The Netherlands (data provided by Diabeter), New Zealand, Northern Ireland, Norway, Republic of Ireland, Scotland, Sweden, Ukraine, USA, and Wales.
Discussing their findings, the researchers said “it is clear that there is scope for improvement in the glycaemic control of type 1 diabetes in all countries”. They said a next step could be to investigate whether identifying the reasons for between-country differences in HbA1c levels could help improve future outcomes.
For PubMed abstract click here.